Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products
/PRNewswire/ -- Neukio Biotherapeutics, a company committed to developing novel cell therapy products, announces it has closed $50 million in a Series A-1...
Source: prnewswire.com